BIOVENTIX PLC
For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer Bioventix
of existing shares to which voting rights are (Sedol
attached: ii B4QVDF0)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights
Other (please
specify):
3. Full name of person(s) subject to CASTLEFIELD FUND PARTNERS LIMITED
the
notification obligation: iii
4. Full name of shareholder(s)
(if different from 3.):iv
5. Date of the transaction and date 9th January 2017
on
which the threshold is crossed or
reached: v
6. Date on which issuer notified:
12th January 2017
7. Threshold(s) that is/are crossed 5%
or
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering transaction
shares to the triggering
transaction
if possible
using Number Number Number Number of voting % of voting rights x
the ISIN CODE of of of shares rights
Shares Voting
Rights Direct Direct xi Indirect Direct Indirect
xii
250,000 250,000 265,000 265,000 5.197%
GB00B4QVDF07
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rights
instrument price date xvii Conversion instrument refers to xix, xx
period xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
265,000 5.197%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information: Percentage based on Issued Share Capital of
5,098,656
14. Contact name: Richard Vickers
15. Contact telephone number: 0161 233 4890
Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification
obligation
Full name
(including legal form of legal entities)
Contact address
(registered office for legal entities)
Phone number & email
Other useful information
(at least legal representative for legal
persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information
(e.g. functional relationship with the
person or legal entity subject to the
notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.
Bioventix : s) in Company
January 13, 2017 at 09:27 pm IST
Share
Share
© PRNewswire - 2017
